Genetic prodrug activation therapy for pancreatic cancer

Ann N Y Acad Sci. 1999 Jun 30:880:319-25. doi: 10.1111/j.1749-6632.1999.tb09535.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Animals
  • Biotransformation
  • Genetic Therapy / methods*
  • Humans
  • Pancreatic Neoplasms / drug therapy*
  • Prodrugs / metabolism
  • Prodrugs / therapeutic use*

Substances

  • Prodrugs